Table 3 ∣.
Adverse events/toxicities new or worsening relative to enrollment, at least possibly related to treatment
Toxicity grade CTCAE v4.0 | |||||
---|---|---|---|---|---|
01-Mild | 02-Moderate | 03-Severe | 04-Life threatening | ||
Toxicity category CTCAE v4.0 | Toxicity description CTCAE v4.0 | N | N | N | N |
Blood and lymphatic system disorders | Anemia | 2 | 2 | – | – |
Elevated white blood cells | – | 1 | – | – | |
Hepatotoxicity | – | 1 | – | – | |
Cardiac disorders | Ventricular tachycardia | 1 | – | – | – |
Ear and labyrinth disorders | Vertigo | 1 | – | – | – |
Endocrine disorders | Adrenal insufficiency | 1 | 1 | 1 | – |
Hyperthyroidism | 1 | – | – | – | |
Hypophysitis | – | – | 1 | – | |
Hypothyroidism | 2 | 1 | – | – | |
Eye disorders | Blurred vision | 1 | – | – | – |
Conjunctivitis | 1 | 1 | – | – | |
Double vision | 1 | – | – | – | |
Dry eye | 1 | – | – | – | |
Itchiness, right eye | 1 | – | – | – | |
Visual changes | – | 1 | – | – | |
Watering eyes | 1 | – | – | – | |
Gastrointestinal disorders | Abdominal distension | – | – | 1 | – |
Abdominal pain | 2 | – | 1 | – | |
Colitis | 1 | 1 | – | – | |
Constipation | 4 | – | – | – | |
Diarrhea | 4 | 1 | 1 | – | |
Duodenal hemorrhage | 1 | – | – | – | |
Dyspepsia | 1 | – | – | – | |
Gastroesophageal reflux disease | 1 | – | 1 | – | |
Mouth sore | 1 | – | – | – | |
Nausea | 8 | 6 | 1 | – | |
Vomiting | 4 | 6 | – | – | |
General disorders and admin site conditions | Chills | 4 | – | – | – |
Edema, limbs | 1 | 1 | – | – | |
Facial numbness with lip tingling | 1 | – | – | – | |
Fatigue | 14 | 9 | 1 | – | |
Fever | 2 | 1 | – | – | |
Gait disturbance | 2 | 2 | – | – | |
Localized edema | 1 | – | – | – | |
Malaise | 4 | 1 | – | – | |
Night sweats | 1 | – | – | – | |
Infections and infestations | Infection, other; influenza B | – | 1 | – | – |
Oral Thrush | – | 1 | – | – | |
Sinusitis | – | 1 | – | – | |
Upper respiratory infection | – | 1 | – | – | |
Investigations | Alanine aminotransferase increased | 6 | 1 | 1 | – |
Alkaline phosphatase increased | – | 1 | 1 | – | |
Aspartate aminotransferase increased | 6 | 1 | 3 | – | |
Blood bilirubin increased | 1 | – | – | – | |
Elevated thyroid-stimulating hormone | 1 | – | – | – | |
Lymphocyte count decreased | 1 | – | 1 | – | |
Platelet count decreased | 1 | 2 | – | – | |
Weight gain | 1 | – | – | – | |
Weight loss | 1 | – | – | – | |
Decreased white blood cells | 1 | 1 | – | – | |
Metabolism and nutrition disorders | Anorexia | 7 | 2 | – | – |
Hyperglycemia | 3 | – | – | – | |
Hypokalemia | – | – | 2 | – | |
Hypomagnesemia | 1 | – | – | – | |
Hyponatremia | 4 | – | 1 | – | |
Hypophosphatemia | – | 2 | – | – | |
Transaminitis | 1 | – | – | – | |
Musculoskeletal and connective tissue disorders | Arthralgia | 3 | – | – | – |
Back pain | – | 2 | – | – | |
Body aches | 1 | – | – | – | |
Bone pain | 1 | – | – | – | |
Generalized muscle weakness | 3 | 1 | 2 | – | |
Muscle cramps, back and legs | 1 | – | – | – | |
Muscle weakness, left-sided | 1 | – | – | – | |
Muscle weakness, lower limb | 1 | – | – | – | |
Muscle weakness, right-sided | – | 1 | – | – | |
Myalgia | 5 | – | – | – | |
Myositis | – | 1 | – | – | |
Neck pain | 2 | – | – | – | |
Pain in extremity | 1 | – | – | – | |
Nervous system disorders | Cerebral edema | – | 1 | 1 | 2 |
Dizziness | 4 | 1 | – | – | |
Dysarthria | – | 1 | – | – | |
Dysgeusia | 4 | 1 | – | – | |
Expressive aphasia | – | 1 | – | – | |
Facial muscle weakness | 1 | – | – | – | |
Headache | 6 | 4 | 2 | – | |
Memory impairment | 1 | – | – | – | |
Seizure | 4 | – | – | – | |
Somnolence | – | 1 | – | – | |
Syncope | – | – | 1 | – | |
Psychiatric disorders | Anxiety | 1 | – | – | – |
Confusion | 2 | – | 4 | – | |
Delirium | – | – | 1 | – | |
Depression | 1 | – | – | – | |
Insomnia | 5 | – | – | – | |
Respiratory, thoracic and mediastinal disorders | Cough | 3 | 1 | – | – |
Dyspnea | 3 | – | – | – | |
Pneumonitis | 1 | – | – | – | |
Skin and subcutaneous tissue disorders | Alopecia | 1 | – | – | – |
Dry skin | 1 | – | – | – | |
Itchy skin | – | 1 | – | – | |
Pruritus | 3 | – | – | – | |
Rash, acneiform | 2 | – | – | – | |
Rash, maculopapular | 2 | – | – | – | |
Vascular disorders | Hypertension | – | 1 | – | – |
Hypotension | – | 1 | – | – |
CTCAE, Common Terminology Criteria for Adverse Events.